Risk Factors Update Summary
- Increased competition in R&D activities may lead to decreased market share and pricing power.
- Consolidation in the animal health industry may result in competitors gaining efficiencies and market share.
- Safety, quality, or efficacy concerns about products could impact a significant portion of sales.
- Dependence on top-selling products like Simparica Trio and Apoquel may impact revenue.
- Climate-driven changes could adversely affect manufacturing processes and supply chain.
- Changes in currency exchange rates, including those in highly inflationary economies, may impact revenue.
- Cybersecurity risks, including cyberattacks and breaches, could negatively impact operations and financial condition.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1555280&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.